Merck Tops Estimates As Top Line Rises 1%, Reaffirms Guidance (MRK) "

Published on Sun, 07/29/2012 - 09:22
By FNNO Staff in business, finance, merck, nasdaq, news, nyse, stock, trading
finance, news, stock, business, trading, nyse, nasdaq, merck

7-27-12-Merck (NYSE:MRK) reported Q2 EPS of $1.05, beating estimates by $0.03. Revenues in the quarter rose 1% year-over-year to $12.3 billion, beating estimates by $140 million. The company still sees 2012 adjusted EPS of $3.75-$3.85, vs. estimates of $3.83. Merck also reiterated annual revenue at or near 2011 levels with constant FX. At current exchange rates, sales would be hurt by about 6% in Q3, 3% for the year.

By FNNO Staff
fnnonline@gmail.com

Most Popular Video News